| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.5M | +114.3% |
| Cost of Revenue | $10.6M | +30.1% |
| Gross Profit | $913K | +132.9% |
| R&D Expense | $2.9M | -58.2% |
| SG&A Expense | $15.6M | -15.0% |
| Operating Income | -$19.9M | +32.0% |
| Pre-tax Income | -$24.0M | +31.4% |
| Income Tax | $0 | — |
| Net Income | -$24.0M | +31.4% |
| EPS (Basic) | -$171.77 | -5.2% |
| EPS (Diluted) | -$171.77 | -5.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $512K | +271.0% |
| Accounts Receivable | $2.6M | +83.3% |
| Inventory | $7.3M | +9.6% |
| Current Assets | $14.7M | +78.9% |
| Total Assets | $46.8M | +37.1% |
| Current Liabilities | $31.3M | +16.4% |
| Total Liabilities | $38.1M | +41.0% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.4M | +29.7% |
| Capital Expenditures | $94K | — |
| Investing Cash Flow | -$53.7M | -3108.2% |
| Financing Cash Flow | $64.6M | +295.5% |
| Free Cash Flow | -$10.5M | +29.1% |
| $6.4M |
| -10.2% |